You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 41 No. 10, October 1984 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Reaction Time and Vigilance in Parkinson's Disease

Possible Role of Altered Norepinephrine Metabolism

Yaakov Stern, PhD; Richard Mayeux, MD; Lucien Côté, MD

Arch Neurol. 1984;41(10):1086-1089.


Abstract



• Delayed reaction time and diminished vigilance have been observed in Parkinson's disease (PD) but have not been related to biochemical changes in the disease. As norepinephrine is reduced in the brain in PD and this neurotransmitter has been related to attention and learning, we investigated the relationship of neuropsychological measures, including those of reaction time and vigilance, to the norepinephrine metabolite 3- methoxy - 4 - hydroxyphenethyleneglycol (MHPG) in 39 patients with idiopathic PD. The MHPG levels correlated with a measure of general intellectual ability and with performance on reaction time and continuous performance tasks. Our data suggest that altered norepinephrine metabolism may contribute to some aspects of intellectual dysfunction in PD.



Author Affiliations



From the Departments of Neurology (Drs Stern, Mayeux, and Côté) and Rehabilitation Medicine (Dr Côté), Columbia University College of Physicians and Surgeons, New York.


Footnotes



Accepted for publication Jan 27, 1984.

Presented in part before the 35th annual meeting of the American Academy of Neurology, April 28, 1983, San Diego.

Reprint requests to 710 W 168th St, New York, NY 10032 (Dr Mayeux).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Noradrenergic Modulation of Subthalamic Nucleus Activity: Behavioral and Electrophysiological Evidence in Intact and 6-Hydroxydopamine-Lesioned Rats
Belujon et al.
J. Neurosci. 2007;27:9595-9606.
ABSTRACT | FULL TEXT  

Cognition following bilateral implants of embryonic dopamine neurons in PD: A double blind study
Trott et al.
Neurology 2003;60:1938-1943.
ABSTRACT | FULL TEXT  

P3 Latency Change in Aging and Parkinson Disease
Tachibana et al.
Arch Neurol 1997;54:296-302.
ABSTRACT  

Dementia: A Review Emphasizing Clinicopathologic Correlation and Brain-Behavior Relationships
Chui
Arch Neurol 1989;46:806-814.
ABSTRACT  

Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates
Cummings
J Geriatr Psychiatry Neurol 1988;1:24-36.
ABSTRACT  

Reaction Time and Catecholamine in Parkinson's Disease
Peiro et al.
Arch Neurol 1988;45:15-15.
ABSTRACT  

Acute Confusional State and Acute Agitated Delirium: Occurrence After Infarction in the Right Middle Cerebral Artery Territory
Mori and Yamadori
Arch Neurol 1987;44:1139-1143.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.